AUROBINDO PHARMA
|
AUROBINDO PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit Before Tax | ₹2,613 Cr | ₹3,373 Cr | ₹7,344 Cr | ₹3,743 Cr | ₹3,091 Cr |
Adjustment | ₹1,586 Cr | ₹1,344 Cr | ₹-1,663 Cr | ₹1,091 Cr | ₹814 Cr |
Changes In working Capital | ₹-1,095 Cr | ₹1,558 Cr | ₹-1,067 Cr | ₹308 Cr | ₹-1,485 Cr |
Cash Flow after changes in Working Capital | ₹3,104 Cr | ₹6,275 Cr | ₹4,614 Cr | ₹5,142 Cr | ₹2,421 Cr |
Cash Flow from Operating Activities | ₹2,387 Cr | ₹5,016 Cr | ₹3,329 Cr | ₹4,381 Cr | ₹1,651 Cr |
Cash Flow from Investing Activities | ₹-3,978 Cr | ₹-3,212 Cr | ₹599 Cr | ₹-1,568 Cr | ₹-2,903 Cr |
Cash Flow from Financing Activities | ₹1,814 Cr | ₹-2,969 Cr | ₹-1,365 Cr | ₹-1,947 Cr | ₹1,919 Cr |
Net Cash Inflow / Outflow | ₹223 Cr | ₹-1,164 Cr | ₹2,563 Cr | ₹866 Cr | ₹667 Cr |
Opening Cash & Cash Equivalents | ₹4,163 Cr | ₹5,330 Cr | ₹2,747 Cr | ₹1,876 Cr | ₹1,210 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | ₹6.41 Cr | ₹-3.25 Cr | ₹22 Cr | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | ₹-0.06 Cr | ₹0.20 Cr | ₹-2.12 Cr | ₹4.78 Cr | ₹-1.80 Cr |
Closing Cash & Cash Equivalent | ₹4,392 Cr | ₹4,163 Cr | ₹5,330 Cr | ₹2,747 Cr | ₹1,876 Cr |
Compare Cashflow Statement of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹63,693.2 Cr | 6.4% | 0.8% | 117.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 6.4% |
0.8% |
117.4% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses